78 related articles for article (PubMed ID: 27466488)
1. ID1 Controls Aggressiveness of Salivary Gland Cancer Cells via Crosstalk of IGF and AKT Pathways.
Sumida T; Kamata YU; Kobayashi Y; Ishikawa A; Mori Y
Anticancer Res; 2016 Aug; 36(8):3865-70. PubMed ID: 27466488
[TBL] [Abstract][Full Text] [Related]
2. Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.
Sumida T; Murase R; Onishi-Ishikawa A; McAllister SD; Hamakawa H; Desprez PY
BMC Cancer; 2013 Mar; 13():141. PubMed ID: 23517130
[TBL] [Abstract][Full Text] [Related]
3. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
[TBL] [Abstract][Full Text] [Related]
4. ID1 contributes to cell growth invasion and migration in salivary adenoid cystic carcinoma.
Hu XM; Lin T; Huang XY; Gan RH; Zhao Y; Feng Y; Ding LC; Su BH; Zheng DL; Lu YG
Mol Med Rep; 2017 Dec; 16(6):8907-8915. PubMed ID: 29039489
[TBL] [Abstract][Full Text] [Related]
5. Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression.
Murase R; Sumida T; Kawamura R; Onishi-Ishikawa A; Hamakawa H; McAllister SD; Desprez PY
Cancer Lett; 2016 Jul; 377(1):11-6. PubMed ID: 27087608
[TBL] [Abstract][Full Text] [Related]
6. Targeting ID2 expression triggers a more differentiated phenotype and reduces aggressiveness in human salivary gland cancer cells.
Sumida T; Ishikawa A; Nakano H; Yamada T; Mori Y; Desprez PY
Genes Cells; 2016 Aug; 21(8):915-20. PubMed ID: 27364596
[TBL] [Abstract][Full Text] [Related]
7. Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway.
Cheng YJ; Tsai JW; Hsieh KC; Yang YC; Chen YJ; Huang MS; Yuan SS
Cancer Lett; 2011 Aug; 307(2):191-9. PubMed ID: 21536374
[TBL] [Abstract][Full Text] [Related]
8. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Id1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway.
Yang G; Zhang Y; Xiong J; Wu J; Yang C; Huang H; Zhu Z
Mol Med Rep; 2012 Apr; 5(4):1075-9. PubMed ID: 22245935
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
11. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
12. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of DNA-binding protein 1 knockdown arrests the growth of colorectal cancer cells and suppresses hepatic metastasis in vivo.
Lai X; Liao J; Lin W; Huang C; Li J; Lin J; Chen Q; Ye Y
Oncol Rep; 2014 Jul; 32(1):79-88. PubMed ID: 24804700
[TBL] [Abstract][Full Text] [Related]
14. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
[TBL] [Abstract][Full Text] [Related]
15. Silencing IGF-II impairs C-myc and N-ras expressions of SMMC-7721 cells via suppressing FAK/PI3K/Akt signaling pathway.
Ji Y; Wang Z; Li Z; Huang N; Chen H; Li B; Hui B
Cytokine; 2017 Feb; 90():44-53. PubMed ID: 27768959
[TBL] [Abstract][Full Text] [Related]
16. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells.
Kuang X; Xiong J; Lu T; Wang W; Zhang Z; Wang J
Int J Med Sci; 2021; 18(1):245-255. PubMed ID: 33390793
[TBL] [Abstract][Full Text] [Related]
18. Apicidin inhibits cell growth by downregulating IGF-1R in salivary mucoepidermoid carcinoma cells.
Ahn MY; Ahn JW; Kim HS; Lee J; Yoon JH
Oncol Rep; 2015 Apr; 33(4):1899-907. PubMed ID: 25647264
[TBL] [Abstract][Full Text] [Related]
19. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
[TBL] [Abstract][Full Text] [Related]
20. Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II.
Sung CH; Im HJ; Park N; Kwon Y; Shin S; Ye DJ; Cho NH; Park YS; Choi HK; Kim D; Chun YJ
Toxicol Lett; 2013 Nov; 223(2):109-15. PubMed ID: 24055520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
